{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:22:38Z","timestamp":1793506958522,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pancreatic <jats:italic>\u03b2<\/jats:italic>-cell death and dysfunction contributes to the pathogenesis of both type 1 and type 2 diabetes. We aimed to examine whether the regulator of G protein signaling protein 2 (RGS2), a multifunctional inhibitor of G protein-coupled receptor (GPCR) signaling, impacts <jats:italic>\u03b2<\/jats:italic>-cell death and function. Metabolic phenotypes, <jats:italic>\u03b2<\/jats:italic>-cell secretory function, and glucose and insulin tolerance were measured in RGS2 knockout (RGS2<jats:sup>\u2212\/\u2212<\/jats:sup>) mice and their wild-type (RGS2<jats:sup>+\/+<\/jats:sup>) littermate controls. <jats:italic>\u03b2<\/jats:italic>-Cell death was evaluated in RGS2-knockdown and -overexpressing <jats:italic>\u03b2<\/jats:italic> cells and RGS2<jats:sup>\u2212\/\u2212<\/jats:sup> islets by flow cytometry, western blot, ELISA, TUNEL staining, and apoptosis RT<jats:sup>2<\/jats:sup> profiler PCR array analysis. <jats:italic>\u03b2<\/jats:italic>-Cell mass was evaluated in pancreases from RGS2<jats:sup>\u2212\/\u2212<\/jats:sup> and RGS2<jats:sup>+\/+<\/jats:sup> mice at 1 day, 4 weeks, and 25 weeks of age. Our data show that RGS2<jats:sup>\u2212\/\u2212<\/jats:sup> islets secreted more insulin than RGS2<jats:sup>+\/+<\/jats:sup> islets when challenged with glucose or exendin-4. RGS2-knockdown cells are susceptible to hypoxia induced cell death while RGS2-overexpressing cells are protected from cell death. Depletion of RGS2 in islets alters expression of apoptosis-related genes and RGS2<jats:sup>\u2212\/\u2212<\/jats:sup> islets are prone to apoptosis compared with RGS2<jats:sup>+\/+<\/jats:sup> islets. Ultimately, excessive insulin secretion and increased <jats:italic>\u03b2<\/jats:italic>-cell apoptosis contributed to a 70% reduction in pancreatic <jats:italic>\u03b2<\/jats:italic>-cell mass in RGS2<jats:sup>\u2212\/\u2212<\/jats:sup> mice compared with RGS2<jats:sup>+\/+<\/jats:sup> mice at 25 weeks of age. RGS2 has critical roles in maintaining pancreatic <jats:italic>\u03b2-<\/jats:italic>cell mass via modulating <jats:italic>\u03b2-<\/jats:italic>cell function and apoptosis. It may serve as a druggable target to help prevent pancreatic <jats:italic>\u03b2<\/jats:italic>-cell loss in the treatment of diabetes.<\/jats:p>","DOI":"10.1038\/cddis.2016.216","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T16:54:22Z","timestamp":1495731262000},"page":"e2821-e2821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Regulator of G protein signaling 2 is a key regulator of pancreatic \u03b2-cell mass and function"],"prefix":"10.1038","volume":"8","author":[{"given":"H","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D S","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Sj\u00f6gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Luttrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"key":"BFcddis2016216_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/nyas.12031","volume":"1281","author":"GC Weir","year":"2013","unstructured":"Weir GC, Bonner-Weir S . Islet beta cell mass in diabetes and how it relates to function, birth, and death. Ann NY Acad Sci 2013; 1281: 92\u2013105.","journal-title":"Ann NY Acad Sci"},{"key":"BFcddis2016216_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0891-5849(96)02051-5","volume":"20","author":"S Lenzen","year":"1996","unstructured":"Lenzen S, Drinkgern J, Tiedge M . Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996; 20: 463\u2013466.","journal-title":"Free Radic Biol Med"},{"key":"BFcddis2016216_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2337\/diab.45.9.1161","volume":"45","author":"AM Davalli","year":"1996","unstructured":"Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC . Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45: 1161\u20131167.","journal-title":"Diabetes"},{"issue":"Suppl 4","key":"BFcddis2016216_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1463-1326.2008.00939.x","volume":"10","author":"AV Matveyenko","year":"2008","unstructured":"Matveyenko AV, Butler PC . Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab 2008; 10 (Suppl 4): 23\u201331.","journal-title":"Diabetes Obes Metab"},{"key":"BFcddis2016216_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1210\/er.2007-0031","volume":"29","author":"M Salehi","year":"2008","unstructured":"Salehi M, Aulinger BA, D'Alessio DA . Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins. Endocr Rev 2008; 29: 367\u2013379.","journal-title":"Endocr Rev"},{"key":"BFcddis2016216_CR6","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1172\/JCI110398","volume":"68","author":"RN Bergman","year":"1981","unstructured":"Bergman RN, Phillips LS, Cobelli C . Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981; 68: 1456\u20131467.","journal-title":"J Clin Invest"},{"key":"BFcddis2016216_CR7","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","volume":"42","author":"SE Kahn","year":"1993","unstructured":"Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42: 1663\u20131672.","journal-title":"Diabetes"},{"key":"BFcddis2016216_CR8","doi-asserted-by":"publisher","first-page":"14389","DOI":"10.1073\/pnas.94.26.14389","volume":"94","author":"SP Heximer","year":"1997","unstructured":"Heximer SP, Watson N, Linder ME, Blumer KJ, Hepler JR . RGS2\/G0S8 is a selective inhibitor of Gqalpha function. Proc Natl Acad Sci USA 1997; 94: 14389\u201314393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2016216_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1172\/JCI15598","volume":"111","author":"SP Heximer","year":"2003","unstructured":"Heximer SP, Knutsen RH, Sun X, Kaltenbronn KM, Rhee MH, Peng N et al. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest 2003; 111: 445\u2013452.","journal-title":"J Clin Invest"},{"key":"BFcddis2016216_CR10","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1210\/endo.139.11.6282","volume":"139","author":"CC Tseng","year":"1998","unstructured":"Tseng CC, Zhang XY . Role of regulator of G protein signaling in desensitization of the glucose-dependent insulinotropic peptide receptor. Endocrinology 1998; 139: 4470\u20134475.","journal-title":"Endocrinology"},{"key":"BFcddis2016216_CR11","doi-asserted-by":"publisher","first-page":"12272","DOI":"10.1073\/pnas.220414397","volume":"97","author":"AJ Oliveira-Dos-Santos","year":"2000","unstructured":"Oliveira-Dos-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, Whishaw IQ et al. Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci USA 2000; 97: 12272\u201312277.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2016216_CR12","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1210\/en.2005-1532","volume":"147","author":"DG Romero","year":"2006","unstructured":"Romero DG, Plonczynski MW, Gomez-Sanchez EP, Yanes LL, Gomez-Sanchez CE . RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells. Endocrinology 2006; 147: 3889\u20133897.","journal-title":"Endocrinology"},{"key":"BFcddis2016216_CR13","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1083\/jcb.200811058","volume":"186","author":"CH Nguyen","year":"2009","unstructured":"Nguyen CH, Ming H, Zhao P, Hugendubler L, Gros R, Kimball SR et al. Translational control by RGS2. J Cell Biol 2009; 186: 755\u2013765.","journal-title":"J Cell Biol"},{"key":"BFcddis2016216_CR14","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.2337\/diabetes.54.5.1400","volume":"54","author":"H Wang","year":"2005","unstructured":"Wang H, Lee SS, Gao W, Czismadia E, McDaid J, Ollinger R et al. Donor treatment with carbon monoxide can yield islet allograft survival and tolerance. Diabetes 2005; 54: 1400\u20131406.","journal-title":"Diabetes"},{"key":"BFcddis2016216_CR15","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.2337\/db06-1513","volume":"56","author":"LC Alonso","year":"2007","unstructured":"Alonso LC, Yokoe T, Zhang P, Scott DK, Kim SK, O'Donnell CP, Garcia-Oca\u00f1a A . Glucose infusion in mice: a new model to induce beta-cell replication. Diabetes 2007; 56: 1792\u20131801.","journal-title":"Diabetes"},{"key":"BFcddis2016216_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2337\/diabetes.52.1.124","volume":"52","author":"J Buteau","year":"2003","unstructured":"Buteau J, Foisy S, Joly E, Prentki M . Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 2003; 52: 124\u2013132.","journal-title":"Diabetes"},{"key":"BFcddis2016216_CR17","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1432-2277.2011.01332.x","volume":"24","author":"J Gao","year":"2011","unstructured":"Gao J, Tian L, Weng G, Bhagroo NV, Sorenson RL, O'Brien TD et al. Stimulating beta cell replication and improving islet graft function by GPR119 agonists. Transpl Int 2011; 24: 1124\u20131134.","journal-title":"Transpl Int"},{"key":"BFcddis2016216_CR18","doi-asserted-by":"publisher","first-page":"19601","DOI":"10.1073\/pnas.0704796104","volume":"104","author":"T Xie","year":"2007","unstructured":"Xie T, Chen M, Zhang QH, Ma Z, Weinstein LS . Beta cell-specific deficiency of the stimulatory G protein alpha-subunit Gsalpha leads to reduced beta cell mass and insulin-deficient diabetes. Proc Natl Acad Sci USA 2007; 104: 19601\u201319606.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2016216_CR19","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1073\/pnas.1319378112","volume":"112","author":"M Berger","year":"2015","unstructured":"Berger M, Scheel DW, Macias H, Miyatsuka T, Kim H, Hoang P et al. Galphai\/o-coupled receptor signaling restricts pancreatic beta-cell expansion. Proc Natl Acad Sci USA 2015; 112: 2888\u20132893.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2016216_CR20","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1172\/JCI29103","volume":"116","author":"M Prentki","year":"2006","unstructured":"Prentki M, Nolan CJ . Islet beta cell failure in type 2 diabetes. J Clin Invest 2006; 116: 1802\u20131812.","journal-title":"J Clin Invest"},{"key":"BFcddis2016216_CR21","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1124\/mol.104.005215","volume":"67","author":"AE Brady","year":"2005","unstructured":"Brady AE, Wang Q, Allen PB, Rizzo M, Greengard P, Limbird LE et al. Alpha 2-adrenergic agonist enrichment of spinophilin at the cell surface involves beta gamma subunits of Gi proteins and is preferentially induced by the alpha 2\u2009A-subtype. Mol Pharmacol 2005; 67: 1690\u20131696.","journal-title":"Mol Pharmacol"},{"key":"BFcddis2016216_CR22","doi-asserted-by":"publisher","first-page":"12541","DOI":"10.1074\/jbc.M111.332130","volume":"287","author":"P Osei-Owusu","year":"2012","unstructured":"Osei-Owusu P, Sabharwal R, Kaltenbronn KM, Rhee MH, Chapleau MW, Dietrich HH et al. Regulator of G protein signaling 2 deficiency causes endothelial dysfunction and impaired endothelium-derived hyperpolarizing factor-mediated relaxation by dysregulating Gi\/o signaling. J Biol Chem 2012; 287: 12541\u201312549.","journal-title":"J Biol Chem"},{"key":"BFcddis2016216_CR23","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1172\/JCI41541","volume":"120","author":"A Sassmann","year":"2010","unstructured":"Sassmann A, Gier B, Gr\u00f6ne HJ, Drews G, Offermanns S, Wettschureck N et al. The Gq\/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice. J Clin Invest 2010; 120: 2184\u20132193.","journal-title":"J Clin Invest"},{"key":"BFcddis2016216_CR24","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1210\/en.2007-1059","volume":"149","author":"NS Sauter","year":"2008","unstructured":"Sauter NS, Schulthess FT, Galasso R, Castellani LW, Maedler K . The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 2008; 149: 2208\u20132218.","journal-title":"Endocrinology"},{"key":"BFcddis2016216_CR25","doi-asserted-by":"crossref","unstructured":"Nguyen CH, Zhao P, Sobiesiak AJ, Chidiac P. RGS2 is a component of the cellular stress response. Biochem Biophys Res Commun 2012; 426: 129\u2013134..","DOI":"10.1016\/j.bbrc.2012.08.050"},{"key":"BFcddis2016216_CR26","doi-asserted-by":"crossref","unstructured":"Klinger S, Poussin C, Debril MB, Dolci W, Halban PA, Thorens B. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14. Diabetes 2008; 57: 584\u2013593..","DOI":"10.2337\/db07-1414"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2016216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016216","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cddis.2016.216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2016216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T17:51:14Z","timestamp":1671731474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2016216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,25]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5]]}},"alternative-id":["BFcddis2016216"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2016.216","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,25]]},"assertion":[{"value":"23 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}